🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New online! Redefining cancer care: the case for an onco-gastroenterology subspecialty bit.ly/3FnDxdV

🌍 Today is World Digestive Health Day! 🗓️ May 29, 2025 🧠 Theme: Nourish to Flourish 🥗 Let's prioritize our gut health with balanced diets, hydration, and mindful eating. #WDHD2025 #GutHealth #NourishToFlourish

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer NEJM doi.org/10.1056/NEJMoa… 💪impressive survival of 30 months in BRAF V600E mCRC 🧐Practice changing! ESMO - Eur. Oncology

Wonderful to see this out in the NEJM today. Structured exercise improves survival in colon cancer! Do come to see #ChrisBooth present in hall B1 at 4 30 PM today ASCO nejm.org/doi/full/10.10…

#ASCO25 What does >10 MET-hrs/week actually look like and how can we break it down for patients? That was the CHALLENGE trial target —and it delivered a DFS HR of 0.72. But this isn’t just a number. It’s a prescription. 💡 1 MET = resting energy 10 MET-hrs/week = 150–300 min of

If you’re a GI/HPB surgeon/oncologist who couldn’t make it to ASCO 2025 & trying to scour for its ongoings online like I have been, here’s the 2 trials you’d probably be interested in with a concise breakdown: MATTERHORN, & CASSANDRA! (Also tagging ppl who are smarter than me)

A 3-year structured exercise programme after adjuvant chemo for colon cancer lead to: - significantly longer disease-free survival (DFS) (HR 0.72; 95% CI, 0.55 to 0.94; P=0.02) - better 5-year DFS (80.3% vs 73.9%) - better OS at 8 years (90.3% vs 83.2%) nejm.org/doi/full/10.10…

‘If this was a HR of a drug intervention you would get a standing ovation’ Fascinating data presented #ASCO25 on impact of timing of IO administration across the day (before vs. After 15:00)

🔍 Resection of duodenal neuroendocrine tumors presents technical challenges. ✅ EMR with over-the-scope-clip (OTSC) enables safe full-thickness resection with shorter time and fewer complications Tashima et al 🇯🇵 analyzed this in a multicenter study 🔗 onlinelibrary.wiley.com/doi/10.1111/jg…

🛑 Discomfort during EGD can be a barrier, especially in sedation-risk patients. Chiang et al 🇹🇼 show in their RCT that waiting 3⃣ minutes after topical lidocaine spray significantly reduces pain, nausea, and vital signs spike vs. a 1⃣ minute wait ⏱️ 🔗 onlinelibrary.wiley.com/doi/10.1111/jg…

Check out the June issue of the Journal of #Gastroenterology and #Hepatology 📗 ❇️ Role of Nutrition in IBD ❇️ EUS-GJ for Malignant GOO ❇️ Carvedilol vs. Propranolol in Reduction of HVPG ❇️ Timing of Scope Insertion after Lidocaine And more 🔗 onlinelibrary.wiley.com/toc/14401746/2…

CU Medicine holds the top position nationally, and ranks No. 2 in Asia according to the recent "Best Medicine Universities in the World 2025 Ranking" by Research.com, a premier academic platform for researchers. CU Medicine stands out as one of the youngest medical

🎉 CUHK Medicine ranks 2nd globally & 1st in Asia for #Gastroenterology & #Hepatology in the “#BestGlobal Universities Subject Rankings 2025-26” by U.S. News and World Report. We also have 6 subjects ranked 1st in #HongKong & Top 10 in #Asia. #CUMedicine #GlobalRankings

Great to meet Dr Min-Han Tan Lucence at the oncology academic meeting CUHK Medicine and to hear his insights on liquid biopsy in cancer care

CUHK is ranked 37th in the world in the 2025–2026 Best Global Universities Rankings by U.S. News & World Report, rising 5 places from last year and securing the top spot in Hong Kong. Among the ranked subjects, 10 CUHK disciplines are placed in the global top 50, with four ranked

⚖️Full publication of LEANOX Trial Journal of Clinical Oncology ➡️Lean Body Mass–Based vs body-surface area Oxaliplatin Dose Calculation in adjuvant of stage-III colon ca ✅patients without grade ≥2 peripheral neurotoxicity: 67.2% vs 42.1% ✅Similar RFS and OS 👉ascopubs.org/doi/10.1200/JC… ASCO

🚨 STELLAR-303 makes history! First-ever Ph3 trial to show OS benefit of IO in MSS CRC 🎯 Years of grit & belief led us here 🥹 Endless thanks to Exelixis⁩ for the trust & Dr. Hecht for leading this global win with me! 🎉 ⁦UPMC Hillman Cancer Center⁩ ir.exelixis.com/news-releases/…

Prof Chiu 🇨🇳 on ensuring quality in advanced endotherapy - emphasising the vital role of training and proctorship in this rapidly evolving field, as more complex procedures come under our fold. #BSGLIVE2025 BSG International Pradeep Bhandari

The OncoAlert VJ Oncology JOURNAL CLUB This week we have the pleasure to bring you our OncoAlert Colleague Kohei shitara 🇯🇵Discussing his paper: Trastuzumab Durextecan or Ramucirumab plus paclitaxel in gastric cancer out on NEJM nejm.org/doi/10.1056/NE… #OncoAlertAF